Latest Features & Opinion
To date, more than 1,600 cases have been brought into the United States by returning travelers and mosquitoes capable of transmitting are present in much of the US
The FDA now advises against choosing fluoroquinolones to treat certain common infections when alternate antibiotics are available.
Gary Blick, MD, shares his 30+ years of experience in treating HIV.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Fluoroquinolone Restriction Program Reduces Hospital-Acquired C Difficile
- HIV Testing Rates Remain Low at Doctor's Offices, Despite Recommendations
- AMA Urges More Education on Pre-exposure Prophylaxis
- Innovative Approach Spurs More Hand Hygiene Compliance in Hospital
- APIC: Many ED Patients Suspected to Have Chlamydia, Gonorrhea Receive Unnecessary Antibiotics
- Clinician Education Video: CDC Official Discusses Sepsis
- Patient Education Video: FDA Officials Share Tips to Avoid Poisonous Plants
- FDA Officials: Test Donated Blood for Zika Virus
- Vonoprazan-Based Triple Treatment May Be Effective Against H pylori
- Intussusception Hospitalization Rate Increased at Age 8 to 11 Weeks
Review a major breakthrough in Hepatitis B research which focuses on a potential way to destroy the virus.